Teva Pharmaceutical Industries Ltd (TEVA) insider trading
Every open-market stock purchase and sale by Teva Pharmaceutical Industries Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $96.3M over the last 12 months (38 sales). No open-market buys.
- Last insider buy: David R. McAvoy (C-suite exec), $21K, 13 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $96.3M (38 sales). Last close $33.26 on Jun 7, 2026.
Recent TEVA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | Matthew Shields (VP) | Sold | $322K |
| Jun 11, 2026 | Eliyahu Sharon Kalif (CFO) | Sold | $3.6M |
| Jun 5, 2026 | Richard D Francis (CEO) | Sold | $211K |
| Jun 5, 2026 | Chen Lichtenstein (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Ronit Satchi-Fainaro (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Perry Nisen (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Sol J Barer (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Richard D Francis (CEO) | Bought (not open market) | — |
| Jun 5, 2026 | Roberto Mignone (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Rosemary A Crane (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Tal Zvi Zaks (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Amir Elstein (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Gerald M Lieberman (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Matthew Shields (VP) | Sold | $532K |
| Jun 3, 2026 | Matthew Shields (VP) | Bought (not open market) | — |
| May 28, 2026 | Tal Zvi Zaks (Insider) | Bought (not open market) | — |
| May 28, 2026 | Ronit Satchi-Fainaro (Insider) | Bought (not open market) | — |
| May 28, 2026 | Roberto Mignone (Insider) | Bought (not open market) | — |
| May 28, 2026 | Amir Elstein (Insider) | Bought (not open market) | — |
| May 28, 2026 | Gerald M Lieberman (Insider) | Bought (not open market) | — |
| May 28, 2026 | Rosemary A Crane (Insider) | Bought (not open market) | — |
| May 28, 2026 | Sol J Barer (Insider) | Bought (not open market) | — |
| May 28, 2026 | Chen Lichtenstein (Insider) | Bought (not open market) | — |
| May 28, 2026 | Perry Nisen (Insider) | Bought (not open market) | — |
| May 14, 2026 | Eliyahu Sharon Kalif (CFO) | Sold | $5.5M |
Who's trading TEVA
- Matthew Shields, VP: sold $1.4M (3 sales), last Jun 18, 2026
- Eliyahu Sharon Kalif, CFO: sold $20.7M (3 sales), last Jun 11, 2026
- Tal Zvi Zaks, Insider: other filings, last Jun 5, 2026
- Rosemary A Crane, Insider: other filings, last Jun 5, 2026
- Amir Elstein, Insider: other filings, last Jun 5, 2026
- Richard D Francis, CEO: sold $31.3M (7 sales), last Jun 5, 2026
- Gerald M Lieberman, Insider: other filings, last Jun 5, 2026
- Chen Lichtenstein, Insider: other filings, last Jun 5, 2026
- Roberto Mignone, Insider: sold $8.5M (3 sales), last Jun 5, 2026
- Perry Nisen, Insider: other filings, last Jun 5, 2026
- Ronit Satchi-Fainaro, Insider: other filings, last Jun 5, 2026
- Sol J Barer, Insider: other filings, last Jun 5, 2026
- Evan Lippman, VP: sold $1.5M (2 sales), last May 14, 2026
- Amir Weiss, C-suite exec: sold $1.1M (3 sales), last May 6, 2026
- Richard Daniell, VP: sold $12.1M (8 sales), last May 5, 2026
Get free alerts when an insider at Teva Pharmaceutical Industries Ltd files a new trade →